The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales

scientific article published in December 2010

The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2010.08.078
P698PubMed publication ID21055501

P50authorMarc BaguelinQ61045865
Nick AndrewsQ91506784
Elizabeth MillerQ91581573
Julia StoweQ99412893
P2093author name stringMark Jit
Deborah Cromer
P2860cites workEstimating influenza vaccine efficacy from challenge and community-based study dataQ24655781
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenzaQ28146066
Influenza vaccination in pregnancy: current evidence and selected national policies.Q30366784
H1N1 2009 influenza virus infection during pregnancy in the USA.Q30379409
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.Q30380578
Economic value of seasonal and pandemic influenza vaccination during pregnancy.Q30382520
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.Q30384775
Tutorial in biostatistics: the self-controlled case series methodQ33368891
Variations in population health status: results from a United Kingdom national questionnaire surveyQ33762238
Effectiveness of influenza vaccine in health care professionals: a randomized trialQ33855109
Hospital admissions attributable to rotavirus infection in England and WalesQ34391954
Is routine influenza immunization warranted in early pregnancy?Q34986031
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, CanadaQ37055208
Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?Q37192076
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United KingdomQ38494697
Effectiveness of maternal influenza immunization in mothers and infantsQ40409398
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004.Q40470797
Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trialQ40636281
Clinical Trials of Monovalent Influenza A/New Jersey/76 Virus Vaccines in Adults: Reactogenicity, Antibody Response, and Antibody PersistenceQ40859416
The need for validation of statistical methods for estimating respiratory virus-attributable hospitalizationQ44704491
Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adultsQ45785388
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.Q45795094
Concerning: 'Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database'.Q47838022
The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age.Q50124678
Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strainQ57116276
Assessing the burden of influenza and other respiratory infections in England and WalesQ57613559
Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trialQ64130222
Cost-effectiveness of universal influenza vaccination in a pregnant populationQ83886549
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecthuman pregnancyQ11995
molecular medicineQ3523816
P1104number of pages8
P304page(s)115-122
P577publication date2010-11-04
P1433published inVaccineQ7907941
P1476titleThe cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales
P478volume29